Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Bello

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Journal of Neurosurgery|September 4, 2020
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large seriesPierina Navarria, Federico Pessina, Elena Clerici, et al.
Nature Communications|March 10, 2019
Deciphering the complex role of thrombospondin-1 in glioblastoma developmentThomas Daubon, Céline Léon, Kim Clarke, et al.
International Journal of Cancer|April 11, 2025
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomasTiffanie Chouleur, Christèle Etchegaray, Laura Villain, et al.
Frontiers in Neuroscience|April 17, 2020
fMRI-Targeted High-Angular Resolution Diffusion MR Tractography to Identify Functional Language Tracts in Healthy Controls and Glioma PatientsFrancesco Sanvito, Eduardo Caverzasi, Marco Riva, et al.
Frontiers in Immunology|January 27, 2023
Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomasClaudia Carenza, Sara Franzese, Alessandra Castagna, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2017
Prognostic value of molecular and imaging biomarkers in patients with supratentorial gliomaEgesta Lopci, Marco Riva, Laura Olivari, et al.
Neurology|June 16, 2026
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 TumorsFrancesco Bruno, Edoardo Pronello, Luca Bertero, et al.
Cell Reports|October 23, 2021
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functionsValentina Cazzetta, Elena Bruni, Sara Terzoli, et al.
Frontiers in Neurology|February 23, 2026
Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumorsDavid Bouget, Mathilde Gajda Faanes, Asgeir Store Jakola, et al.
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Journal of Neurosurgery|September 4, 2020
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large seriesPierina Navarria, Federico Pessina, Elena Clerici, et al.
Nature Communications|March 10, 2019
Deciphering the complex role of thrombospondin-1 in glioblastoma developmentThomas Daubon, Céline Léon, Kim Clarke, et al.
International Journal of Cancer|April 11, 2025
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomasTiffanie Chouleur, Christèle Etchegaray, Laura Villain, et al.
Frontiers in Neuroscience|April 17, 2020
fMRI-Targeted High-Angular Resolution Diffusion MR Tractography to Identify Functional Language Tracts in Healthy Controls and Glioma PatientsFrancesco Sanvito, Eduardo Caverzasi, Marco Riva, et al.
Frontiers in Immunology|January 27, 2023
Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomasClaudia Carenza, Sara Franzese, Alessandra Castagna, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2017
Prognostic value of molecular and imaging biomarkers in patients with supratentorial gliomaEgesta Lopci, Marco Riva, Laura Olivari, et al.
Neurology|June 16, 2026
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 TumorsFrancesco Bruno, Edoardo Pronello, Luca Bertero, et al.
Cell Reports|October 23, 2021
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functionsValentina Cazzetta, Elena Bruni, Sara Terzoli, et al.
Frontiers in Neurology|February 23, 2026
Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumorsDavid Bouget, Mathilde Gajda Faanes, Asgeir Store Jakola, et al.
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
Pageof 19